Paul Moraviec | |
|---|---|
| Born | April 1958 (age 66–67) |
| Nationality | British |
| Education | Kingston University |
| Occupation | Businessman |
| Title | CEO, Convatec |
| Term | April 2015-October 2018 |
Paul Moraviec (born April 1958) [1] is a British businessman. He was the chief executive officer (CEO) of Convatec, an international medical products and technologies company, listed on the FTSE 100 Index, from April 2015 to October 2018. [2]
Moraviec has a master's degree in marketing from London's Kingston University Business School. [3]
Before joining Convatec, he was vice president, neurosurgery business at Johnson & Johnson, and vice president, international commercialoperations at Abbott Laboratories. [4]
Convatec announced that Moraviec will be retiring with immediate effect on 15 October 2018, and will be succeeded on an interim basis by non-executive director Rick Anderson, who was formerly the chairman of Johnson & Johnson. [5]